Pro-opiomelanocortin (POMC) neurons in the hypothalamus are a critical population of anorexigenic (appetite-suppressing) cells located primarily in the arcuate nucleus (ARC). These neurons produce POMC-derived peptides including α-melanocyte-stimulating hormone (α-MSH), β-endorphin, and adrenocorticotropic hormone (ACTH), which collectively regulate food intake, energy expenditure, stress responses, and pain modulation. The melanocortin pathway centered on POMC neuron signaling is one of the most important regulatory systems for body weight control, acting as the primary counterbalance to NPY/AgRP orexigenic neurons.
POMC neurons function as key integrators of metabolic signals, receiving direct input from circulating leptin and insulin, and responding by releasing peptides that suppress hunger and increase energy expenditure. Unlike the simple on/off switch of NPY/AgRP neurons, POMC neurons exhibit graded, activity-dependent peptide release that fine-tunes metabolic state.
POMC is a 241-amino acid precursor protein that undergoes tissue-specific processing by prohormone convertases (PCSK1, PCSK2). In hypothalamic POMC neurons, the key products are:
| Peptide | Sequence | Primary Receptor | Function |
|---|---|---|---|
| α-MSH | SYSMEHFRWGKPV | MC3R, MC4R | Anorexigenic, energy expenditure |
| β-Endorphin | YGGFMTPEKSQT | μ-opioid receptor | Analgesia, reward |
| ACTH | SYSMEHFRWGKPAKTL | MC2R | Adrenal axis activation |
The balance between α-MSH (agonist) and AgRP (inverse agonist) at MC3R/MC4R determines the net melanocortin tone — a key parameter for metabolic homeostasis.
POMC neurons express melanocortin receptors (primarily MC3R and MC4R) in an autocrine/paracrine manner, allowing α-MSH to regulate their own activity. They also express:
The primary POMC neuron population resides in the arcuate nucleus of the hypothalamus. A smaller population exists in the nucleus tractus solitarius (NTS) of the brainstem, where they regulate nausea, satiety, and visceral responses. The POMC neurons in ARC and NTS arise from distinct embryological origins and have partially overlapping but distinct functions.
Alzheimer's disease is associated with profound metabolic disturbances including anorexia, weight loss, and dysregulated energy expenditure. POMC neurons contribute to these phenotypes:
Parkinson's disease patients commonly experience weight loss, gastrointestinal dysfunction, and metabolic changes that precede motor symptoms. POMC neurons are implicated:
ALS patients frequently develop hypermetabolism and weight loss despite adequate caloric intake. POMC neurons may contribute through autonomic and metabolic dysregulation, though the primary driver of metabolic changes in ALS is thought to be the motor neuron degeneration itself driving systemic catabolism.
| Target | Approach | Disease | Rationale |
|---|---|---|---|
| MC4R | Agonists | AD | Restore melanocortin tone, improve appetite |
| POMC processing | PCSK1 enhancers | AD/PD | Increase α-MSH production |
| Leptin signaling | Sensitizers | AD/PD | Restore metabolic integration |
| mTOR inhibition | Rapamycin | AD | Enhance POMC neuron function |
MC4R agonists (setmelanotide) have shown efficacy in rare genetic obesity syndromes and are being explored for metabolic dysfunction in neurodegeneration. However, the complexity of the melanocortin axis means that systemic agonism can produce unwanted effects on sexual function, blood pressure, and bone metabolism.
| Partner | Interaction | Role |
|---|---|---|
| NPY/AgRP neurons | Mutual inhibition | Energy homeostasis axis |
| Leptin | Leptin receptor signaling | Fed state activation |
| Insulin | Insulin receptor signaling | Meal-related satiety |
| Neuroinflammation | Cytokine modulation | Metabolic dysregulation |